Alnylam Pharmaceuticals shares owned by Mathes Company
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Mathes Company
from 13F filings
Historical chart of Mathes Company investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Mathes Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Mathes Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $382k | 1.2k | 330.74 |
| 2025-12-31 | $459k | 1.2k | 397.40 |
| 2025-09-30 | $527k | 1.2k | 456.28 |
| 2025-06-30 | $377k | 1.2k | 326.41 |